Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B.

SK, Sarin; A, Sood; M, Kumar; A, Arora; D, Amrapurkar; BC, Sharma; A, Konar; YK, Chawla; RK, Jain; V, Nanda; A, Kumar; S, Hissar; P, Lavate; D, Lahoti

doi:10.1111/j.1572-0241.2006.01006.x

Public

Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B.

Shared by NobleBlocks on Jan 1, 2007 • 12:00 AM UTC

Authors:

Sarin SK

Sood A

Kumar M

Abstract

Background Lower hepatitis B virus DNA (HBV DNA) levels are associated with better responses in chronic hepatitis B (CHB). It is unclear whether an initial phase of antiviral treatment to lower HBV DNA levels before adding immunomodulator therapy is more effective than the strategy of using immunomo...

Discussions